Condition

Liver Carcinoma

ClinicalTrials.gov condition label

Clinical trials5
Recruiting2
Common interventions25
Lead sponsors shown3

Clinical trials

5 shown
The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic ProfilingNCT06717295 · 2025-12-20
RECRUITING
The Vanguard Study: Testing a New Way to Screen for CancerNCT06995898 · 2025-06-18
RECRUITING
Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceNCT06789224 · 2022-02-15
COMPLETED
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing SurgeryNCT04955808 · 2017-02-07
SUSPENDED
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17
ACTIVE_NOT_RECRUITING

Common interventions

Biospecimen CollectionPROCEDURE3Laboratory Biomarker AnalysisOTHER2AdavosertibDRUG1AfatinibDRUG1Afatinib DimaleateDRUG1BinimetinibDRUG1Biopsy ProcedurePROCEDURE1CapivasertibDRUG1CATUVABDEVICE1Computed TomographyPROCEDURE1CopanlisibDRUG1Copanlisib HydrochlorideDRUG1CrizotinibDRUG1Cytology Specimen Collection ProcedureOTHER1DabrafenibDRUG1Dabrafenib MesylateDRUG1DasatinibDRUG1DefactinibDRUG1Defactinib HydrochlorideDRUG1Device UsageDEVICE1DiNanoQ: A multi-cancer early detection (MCED) blood testDIAGNOSTIC_TEST1DiNanoTrack: Therapeutic Response Monitoring Blood TestOTHER1Echocardiography TestPROCEDURE1Electronic Health Record ReviewOTHER1ErdafitinibDRUG1

Trial status mix

RECRUITING2
ACTIVE_NOT_RECRUITING1
COMPLETED1
SUSPENDED1

Phase mix

NA2
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.